Immuneering Corp Cl A (IMRX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2023 | 03-2023 | 12-2022 | 09-2022 | 06-2022 | |
| Sales | 0 | 0 | 1 | 38 | 94 |
| Cost of Goods | 0 | 0 | N/A | 19 | 48 |
| Gross Profit | 0 | 0 | 1 | 19 | 47 |
| Operating Expenses | 13,505 | 14,680 | 13,986 | 13,227 | 11,741 |
| Operating Income | -13,505 | -14,680 | -13,985 | -13,188 | -11,646 |
| Other Income | 1,316 | 1,075 | 739 | 344 | 119 |
| Pre-tax Income | -12,189 | -13,604 | -13,246 | -12,844 | -11,527 |
| Net Income Continuous | -12,189 | -13,604 | -13,246 | -12,844 | -11,527 |
| Net Income | $-12,189 | $-13,604 | $-13,246 | $-12,844 | $-11,527 |
| EPS Basic Total Ops | -0.43 | -0.51 | -0.49 | -0.49 | -0.44 |
| EPS Basic Continuous Ops | -0.43 | -0.51 | -0.50 | -0.49 | -0.44 |
| EPS Diluted Total Ops | -0.43 | -0.51 | -0.49 | -0.49 | -0.44 |
| EPS Diluted Continuous Ops | -0.43 | -0.51 | -0.50 | -0.49 | -0.44 |
| EBITDA(a) | $-13,427 | $-14,677 | $-14,015 | $-13,080 | $-11,403 |